Recent years have witnessed an increased interest in the use of multi-criteria decision analysis (MCDA) to improve the quality, consistency, and transparency of priority setting in healthcare.
However, the use of MCDA for health technology assessment (HTA) agencies has been criticized as being “entirely mechanistic.” This webinar presents the debate on the use of MCDA in HTA decision making. Baltussen presents a recent paper, co-authored by 25 MCDA-experts, including a typology of MCDA studies, a review of studies over the period 1990-2017, and a critical assessment of the various study types on their relevance for HTA agencies.
- Discuss the difference between “qualitative MCDA,” “quantitative MCDA,” and “MCDA with decision rules”
- Describe the limitations of especially ‘quantitative MCDA’
- Explain how MCDA can be best used in the future